JOE HEBERT: Open Payments
NPI 1184161895 · DARDANELLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 22 payments from 12 companies in 2025. Trend: 2023 $97 · 2024 $105 · 2025 $488
Food & beverage: $415Education: $73
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $107 |
| Teva Pharmaceuticals USA, Inc. | 1 | $73 |
| SK Life Science, Inc. | 3 | $64 |
| ABBVIE INC. | 3 | $54 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Eisai Inc. | 2 | $32 |
| Neurelis, Inc. | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: KESIMPTA, QULIPTA, INGREZZA, Leqembi, VALTOCO, ULTOMIRIS, VYEPTI, CAPLYTA.
Industry payments across AR — which companies pay providers there.
